ClinCalc Pro
Menu
Calculators Drugs Pathways AI Dx Donate Get the App
Topical Nutritional / Scar Management Pregnancy: Safe for topical use — used for stretch mark prevention in pregnancy (limited efficacy evidence)

Vitamin E (Tocopherol — Topical Scar Management)

Brand names: Bio-Oil, E45 Cream, Dermatix (silicone + Vitamin E)

Adult dose

Dose: Apply to scar 2–3 times daily with massage; start when wound fully epithelialised (no open areas)
Route: Topical
Frequency: Two to three times daily for minimum 3 months
Max: As required
Used as adjunct in scar management — antioxidant properties, may improve scar pliability and colour. Usually combined with scar massage. Evidence for pure topical vitamin E is mixed — silicone gel remains the gold standard for scar prevention. Do not apply to open wounds.

Paediatric dose

Route: Topical
Frequency: Two to three times daily
Max: As required
Safe in children of all ages — apply after wound fully healed. Perform patch test first (contact dermatitis risk).

Dose adjustments

Renal

No adjustment — topical use.

Hepatic

No adjustment.

Clinical pearls

  • Evidence for topical vitamin E improving scars is inconsistent — RCT evidence does NOT clearly demonstrate superiority over placebo or petroleum jelly. Silicone gel sheeting remains first-line scar prevention.
  • Contact dermatitis risk is surprisingly high — always perform patch test before widespread application. Counsel patients.
  • Scar management hierarchy (evidence-based): 1) Silicone gel/sheeting; 2) Compression; 3) Sun protection; 4) Massage — topical vitamin E is supplementary, not primary therapy

Contraindications

  • Open wounds (apply only to fully healed/epithelialised skin)
  • Known allergy to tocopherol or excipients

Side effects

  • Contact dermatitis (reported in 33% in some studies — patch test first)
  • Skin irritation
  • Comedones (oily formulations)

Interactions

  • Warfarin (systemic vitamin E supplements at high doses can increase anticoagulation — topical use clinically insignificant)

Monitoring

  • Scar appearance, pliability, and pigmentation at each follow-up
  • Skin reaction at application site (contact dermatitis)

Reference: BNFc; BNF 90; BAPRAS Scar Management Guidelines; International Advisory Panel on Scar Management 2014; Cochrane Review on Scar Treatments. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.

Calculators